CVS Health Corp (CVS · NYSE)

CVS · MARKET VIEW

Market view · as of Aug 10, 2026

Revenue (TTM)
$412.64B
+7.1% YoY
Gross margin
13.6%
EPS (latest q)
$2.58
vs $1.87 est · beat
52-wk position
70.5%
-12.9% vs 52w high · -7.5% 1mo

Price (last ~year)

CVS Health reported second-quarter revenue of $106.10 billion and net income of $3.00 billion, marking the company's fourth consecutive earnings beat. While the firm carries $76.31 billion in total debt and a 4.6x debt-to-EBITDA ratio, it generated $9.05 billion in free cash flow as of June 30, 2026. Shares are currently trading at $95.70, down 7.5% over the past month with an RSI of 28.

Valuation

Market cap
$122.40B
P/E
25.25
PEG
0.257
P/B
1.536
P/S
0.297
EV/EBITDA
13.78
Beta
0.596
Analyst target
$115.64

Quality & returns

Gross margin
13.6%
Operating margin
3.9%
Profit margin
1.2%
ROE
6.2%
ROA
3.0%

Price movement

Last
$95.70
1-month
-7.5%
3-month
+1.2%
RSI (14)
28
vs SMA200
+14.0%
52-wk position
70.5% -12.9% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$106.10B$4.70B$3.00B$4.73B
2026-03-31$100.43B$4.68B$2.94B$5.83B
2025-12-31$105.69B$2.11B$2.94B$3.29B
2025-09-30$102.87B$-3.21B$-3.98B$-1.56B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots